
The Ministry of Health allowed clinical studies of the new vaccine from coronavirus to the Chumakov Center. This was reported by the press service of the ministry.
A clinical study will begin in the near future in Kirov, St. Petersburg and Novosibirsk.
“It is planned that more than 3 thousand volunteers will take part in the research, which will meet the requirements of the World Health Organization and international regulators and will ensure research by a reliable volume of scientific data. Voluntary research participants will provide all the necessary information about the procedure, possible benefits, risks and inconvenience, associated with participation in the study, ”the Ministry of Health said.
Participants in clinical studies after vaccination will be in isolation in a hospital for 16 days where doctors will control their condition. Tests are calculated to complete in November.
Currently, the Gam-Kikid-Wak vaccine, developed by the NIC of epidemiology and microbiology named after Gamaley. In addition, it is planned that on September 30, clinical trials of the vaccine developed by the Novosibirsk Center “Vector” will be completed. As stated, documents for its registration may be submitted in October, production began in November.